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Abstract     
This study investigated the levels and the trend of some plasma elements in cancer patients. A total number of 
seven hundred (700) patients with different types of cancer (leukemia, ovarian, prostate, breast, colon, cervical, 
uterine, ovarian) attending University Teaching Hospitals and Federal Medical Centers in Southwestern Nigeria, 
and three hundred (300) healthy subjects who served as control subjects were examined. The plasma levels of Zn, 
Fe, Ca, Mg, Mn and Cu were determined by atomic absorption spectrophotometry while Na and K, were 
analysed using flame emission photometry.The alterations observed in plasma profile of elements of the cancer 
patients when compared with the control may be a useful indicator in the detection of the initial changes 
occurring in neoplastic cells. A significant increase (p<0.05) was recorded in the plasma level of  lead and  
cadmium when compared with the control and among the cancer types which suggests their involvement in the 
generation of reactive oxygen species which could lead to lipid peroxidation,  DNA damage and alteration in 
gene expression. 
Keywords: cancer, elements, plasma, alteration, patients. 
 
Introduction 
Cancer known medically as a malignant neoplasm is a term for a large group of different diseases, all involving 
unregulated cell growth. Cancer is not just one disease but many diseases that all have to do with cells. It results 
from abnormal growth and spreading of cells (Anand et. al., 2008). Normal body cells grow, divide, stop 
growing and over time, they die. Unlike normal cells, cancer cells just continue to grow and divide out of control 
and do not die when they are supposed to (Murgia et. al., 2006). Sometimes, cancer cell breaks away from the 
original tumor and travels to other areas of the body, where they keep growing and can go on to form tumors.  
The spread of a tumor to a new place in the body is called metastasis. Not all tumors are cancerous, tumors can 
be benign or malignant (Kushi et.al., 2006). Benign tumors are not cancerous. They can often be removed, and 
in most cases, they do not come back. Cells in benign tumors do not spread to other parts of the body (Merlo et. 
al., 2006).         
The immune system, which are the immunoglobulin’s, cell mediated immunity, phagocytosis 
complement, lysosome interferon, metabolic function, hormones, metabolic and respiratory alkalosis are the 
natural mechanism. Zinc is essential for normal development and maintenance of the thymus. Reduced antibody 
synthesis, during zinc deficiency relates in part to interferences with T-lymphocyte helper function. Zinc 
promotes B-cell function by acting as a mitogen for animal and human lymphocytes (Cunzhi et. al., 2003). Zinc 
is essential for the normal bactericidal and phagocytic function of granulocytes. Zinc essential role in protein 
synthesis make it essential for normal complement production Acrodermatitis enteropathical, failure to absorb 
zinc because of an inborn error of metabolism, is marked by all the above defects. Blood and serum from patient 
generally show subnormal zinc levels. Zinc deficiency depresses killer cell activity. Zinc deficiency promotes 
cancer by inhibiting normal vitamins A, lipid metabolism and DNA repair (Navarro-Alacron and Lopez-
Martinez 2000). Molybdenum has anti-euplastic properties molybdenum and also manganese prevent the 
formation of some experimentally induced cancer manganese may augment bactericidal action of antibiotics. 
Elevated serum copper levels have been described in patients with a variety of carcinomas. Copper had been 
reported to be a biological antagonist of vitamin C and zinc (Desch et.al., 2005). 
Potassium, the most abundant intracellular cation, is essential for the life of the organism. Potassium is 
obtained through the diet (Durlach et.al.,2000). Potassium homeostasis is maintained predominantly through the 
regulation of renal excretion. The most important site of regulation is the distal nephron, including the distal 
convoluted tubule, the connecting tubule, and the cortical collecting tubule, where aldosterone receptors are 
present (Bios, 2003). Potassium is predominantly an intracellular cation; thus, serum potassium levels can be a 
very poor indicator of total body stores. Potassium moves easily across cell membranes; therefore, serum 
potassium levels reflect the movement of potassium between intracellular and extracellular fluid compartments 
as well as total-body potassium homeostasis (Fuster et.al., 1992). 
Sodium reabsorption through epithelial sodium channels (ENaC) located on the apical membrane of 
cortical collecting tubule cell, is driven by aldosterone and generates a tubular lumen negative electrical potential, 
driving the secretion of potassium at this site through specific potassium channels called the renal outer 
medullary K channels (ROMK) (Doyle et. al., 2007). 
Sodium (Na+), a major cation is considered together with water because their homeostatic mechanisms 
are closely related and inter-dependent. When osmotic pressure increases uncontrollably to a point of saturation, 
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an increase of ECF sodium under this condition may cause the obstruction of the uterus and the uterine cavity, 
distorts menstruation cycle and consequently results to the cancer of the uterus which is better described as 
Endometrial cancer (Harriss et.al 2009).Sodium balance in the body is greatly dependent on the rate of renal 
sodium excretion. The renal excretion of sodium is controlled in the final instance by the glomerular filtration 
Rate (GFR), aldosterone, and the atrial natriuretic peptide (ANP).GFRR influences the tubular absorption rate of 
sodium filtered by the glomerulus (~2500mmol/day). Aldosterone increases the distal tubular reabsorption of 
Na+ and the excretion of H+ and K+. 
Zinc had been reported to inhibit the development of cancer and  low serum zinc had been associated 
with several forms of cancer. When the tumor is associated with tumors rich in zinc, return to normal level was 
associated with a favorable prognosis (Anand et. al., 2008). Aqueous zinc acetate injected intraperitoneally 
prevented tumor growth in 50 to 70 percent of male mice previously inoculated with L1210 leukemia cells. 
Subcutaneous injections in a different strain did not prevent tumor growth but significantly increased mean 
survival (Kuo et. al., 2002). Zinc deficiency has been shown to increase the susceptibility in animals to chemical 
carcinogens that produce esophageal cancer (Manhart and Koutsy 2002). Low zinc levels due to phytate 
consumption have promoting effects on precarcinomatous esophageal tumors. Populations having a usually high 
risk for esophageal cancer tend to subsist on zinc deficient diets, predominantly cereal and have a low intake of 
animal products found that minimal levels of zinc intake which ensure optimal body growth rate are inadequate 
to provide maximal resistance to esophageal carcinogenesis. Zinc may prevent cancer via the metabolism of high 
density lipoprotein (HDL), vitamin A and DNA synthesis (Jemal et. al., 2011). High levels of zinc 
supplementation in normal subjects, 440mg of zinc sulfate per day for five weeks, result in a 25 percent decrease 
below baseline levels of HDL (Al- Ebraheem et. al., 2010). 
Manganese had been found comparable to molybdenum in concentration in animal tissues and fluids of 
all species so far examined. Sarcoma incidence of 96 to 100 percent of rats receiving N1352 was reduced to 63 
percent by manganese dust. Manganese alters the subcellular distribution of carcinogenic nickel (Desch et. al., 
2005). This particular anti-carcinogenic effect was Local, specifically related to the site of injection rather than 
systemic. Manganese may exert its anti-carcinogenic effects by activating superoxide dismutase would be 
inactive and accumulation of superoxide anion could be mutagenic (Kuo et.al., 2002). 
Iron can be carcinogenic in three ways first, ferric ions are reduced by superoxide and the ferrous 
product is re-oxidized by peroxide to regenerate ferric ions and to yield hydroxyl radials (Al- Ebraheem et. al., 
2010). Reactive oxygen species such as hydroxyl radicals, when generated in close proximity to DNA can alter 
normal cells by causing point mutation, DNA cross linking and DNA strand breaks .Oxygen free radicals also 
can cause conformational changes in nuclear and cytoplasmic membranes by inducing lipid predication. 
Secondly, in addition to the initiation of the cancer process, iron can bolster the growth of neoplastic cells by 
suppressing host defenses.  Furthermore the tumoricidal action of macrophages is suppressed by phagocytized 
erythrocytes, erythrocyte lysate, hemoglobin, ion dextran or iron salts, but not by erythrocyte ghost membrane, 
latex spheres myoglobin (Kuo et. al., 2002). The third mechanism whereby iron can be carcinogenic is that of 
functioning as an essential nutrient for unrestricted tumor cells multiplication. Although normal and cells have a 
similar qualitative requirement for iron, the unrestricted proliferation of tumor cells would be expected to require 
an enhanced and probably diversified, supply of the metal. In 1972, Holley proposed that the crucial change in a 
malignant cell is an alteration in the cell surface membrane that results in internal concentration of nutrients that 
regulate cell growth. He noted that the widely differing growth rates of different cancers correspond to change in 
concentrations of intercellular nutrients and that it should be possible to arrest growth of malignant cells in the 
G1 phase of the cell cycle by limiting uptake of a critical nutrient (Desch et.al., 2005). 
Copper is an important trace metal which plays a fundamental role in the biochemistry of the human 
system. It is an important component of several metallo-enzymes including tyrosine and dopamine hydroxylase 
(Liversay, 2003). Copper has been suggested to play an important role in several disorders (Wallwork, 1987). 
Copper ions and copper complexes react with hydrogen peroxide to form hydroxyl radicals that cause  an 
irreparable damage to protein RNA and DNA (Arinola and Charles-Davies, 2008).  Critical proteins such as 
cytochrome oxidase, zinc–copper, superoxide dismutase, lysyl oxidase and several transcription factors require 
copper for activity. Consequently, complex systems for acquiring and regulating copper influx and efflux have 
evolved.  In the yeast Saccharomyces cerevisiae, for example, several essential enzymes are copper dependent. S. 
cerevisae has therefore developed anelaborate system to ensure adequate levels of copper. In an environment 
where copper is scarce, genes are activated to enhance copper uptake.  In mammals, copper balance is 
established by maintaining equilibrium between copper absorption from dietary intake and copper excretion in 
the stool (Bikfalvi and Bicknell, 2002). Based on the tightly controlled homeostasis of copper in primitive 
organisms, the hypothesis that copper availability was a primitive growth regulator, and that this regulatory 
aspect of copper has been maintained throughout evolution had been developed (Brewer 2001a). In the human 
and other mammals, the first observable evidence of copper deficiency is a drop in the level of blood 
ceruloplasmin (Cp) (Brewer et. al., 2000). Cp is a copper-containing protein secreted by the liver into the blood. 
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The copper in Cp accounts for about 90% of the total plasma copper. As copper availability to the liver decreases, 
the liver decreases production and secretion of Cp. Thus, plasma Cp is a good surrogate marker of body copper 
status. There are no known harmful effects of a decreased level of Cp, or the decreased availability of copper, 
associated with moderately reduced Cp levels (defined as areduction of up to 80%). As the Cp becomes very low, 
however, clinical evidence of copper deficiency emerges.The first sign is bone marrow suppression manifested 
as anemia, with or without leukopenia (Brewer et. al., 2000).The next stages of copper deficiency may involve 
connective tissue defects and possibly decreasing bone density if copper deficiency persists. These intermediate 
stages of copper deficiency are not well described in the human. A late stage of copper deficiency, which has 
been seen only very rarely in patients, involves a severe neuropathy in addition to pancytopenia (Bikfalvi and 
Bicknell, 2002). 
Selenium is a vital antioxidant, especially when combined with Vitamin E. As an antioxidant, selenium 
protects the immune system by preventing the formation of free radicals (unbalanced molecules), which can 
damage the body. Selenium and Vitamin E act together to aid in the production of antibodies and to help 
maintain a healthy heart. This trace element (mineral) is needed for pancreatic function and tissue elasticity. A 
selenium deficiency is linked to cancer and heart disease (Kuo et.al.,2002). Selenium exists in both organic and 
inorganic forms. Many studies have shown that the most absorbable form of organic selenium is L-
Selenomethionine. It is not only more absorbable but remains in the body longer, giving it a greater opportunity 
to be utilized by the body. 
 
Materials and Methods 
A total of 700 freshly diagnosed cancer patients (8 different cancer types) and 300 control subjects (healthy 
individual) were examined in this study. 10ml each of their blood samples was collected with the help of medical 
personnels in the University Teaching Hospitals and Federal Medical Centers in SouthWestern Nigeria. 
Intravenous blood (5ml) was carefully collected from the subjects into labelled heparinised bottles. The blood 
sample was immediately centrifuged at 10,000 revolution  per minute (10,000rpm) for ten (10) minutes and 
separated to obtain plasma. The samples were then stored at 4oC prior to analysis. Plasma levels of the elements 
(Fe, Zn, K, Mg, Se, Ca, Pd, Cu, Mn and Cd) were determined using atomic absorption spectophotometry while 
Na and K, were analysed using flame emission photometry as described by AOAC 1990. Statistical analysis was 




Results were expressed as means + standard deviation. Graphs of same parameter with different data labels 
indicate significant difference at (P < 0.05).  
Figure 1: Variation in the levels of element (sodium) within the cancer types and with control subjects. 
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Results were expressed as means + standard deviation. Graphs of same parameter with different data labels 
indicate significant difference at (P < 0.05).  
Figure 2: Variation in the levels of elements (Fe, Zn, Se, Cu and K) within the cancer types and with control 
subjects. 
 
Results were expressed as means + standard deviation. Graphs of same parameter with different data labels 
indicate significant difference at (P < 0.05).  
Figure 3: Variation in the levels of element (Magnesium) within the cancer types and with control subjects. 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 





Results were expressed as means + standard deviation. Graphs of same parameter with different data labels 
indicate significant difference at (P < 0.05).  
Figure 4: Variation in the levels of element (Manganese) within the cancer types and with control subjects. 
 
Results were expressed as means + standard deviation. Graphs of same parameter with different data labels 
indicate significant difference at (P < 0.05).  
Figure 5: Variation in the levels of element (Calcium) within the cancer types and with control subjects. 
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Results were expressed as means + standard deviation. Graphs of same parameter with different data labels 
indicate significant difference at (P < 0.05).  
Figure 6: Variation in the levels of  plasma elements (Lead and Cadmium) within the cancer types and with 
control subjects. 
Figures 1-6 compares the plasma levels of elements in patients with different types of cancer. The 
results revealed no significant difference (P < 0.05) in the plasma levels of Na (Figure 1) in breast, leukemia and 
ovarian (135.87 + 7.07, 138.81 + 3.58  and 135.81 + 3.51) cancer patients respectively while a significant 
increase (P < 0.05) was recorded in liver, colon, uterine, cervical and prostate (146.78 + 4.57, 149.13±4.17, 
148.25 + 2.37 , 148.35 + 3/37 and 150.37 + 1.43) cancer patients respectively when compared with the control 
subjects (138.54 + 0.02). Similarly, kultigin et. al., 2009 reported no significant difference (p< 0.05) in the Na 
level of lung cancer patients. The incidence of hypernatraemia (increase in plasma Na concentration) had been 
reported though by Ashish et. al.,2006 in some types of cancer including prostate, cervical, liver and oesophegal 
cancer. However, hypernatraemia in these types of cancer could be attributed to pure water loss without the signs 
of hypovolaemia (free water loss exceeding sodium loss) such as poor skin tugor, orthostatic hypotension, and 
dry mucous membranes because most of the water is lost from intracellular space which can result from extra-
renal or renal causes.  
Potassium imbalances are potentially life threatening. A wide variety of clinical conditions have been 
associated with aberrant potassium metabolism particularly, patients with cancer have been found to be at higher 
risk (Beverly et. al., 2005). From this study, K (fig.2)  was observed to show no significant difference (P < 0.05) 
in breast, ovarian  and colon (4.68 + 0.44, 5.00 + 0.73 and 4.88 + 0.21,) cancer patients respectively when 
compared to the control subjects (4.78 + 0.030). The trend reported for the value of potassium in this study 
compared favourably with the trend reported by Kultigin et. al.,(2009) for cancer patients. A significantly raised 
(P < 0.05) content of potassium recorded in prostate, liver, leukemia and cervical (5.56 + 0.51, 5.27+  0.24 4.88  
+0.24, 4.68+ 0.44,) cancer patients when compared with the control subjects (4.78 + 0.03) and among the cancer 
patients in this study has also been reported by Fred Schubert (2013). This result may be attributed to the 
breakdown of tumor cells that release potassium from the cell into the blood.   
 Zinc plays an important role in cellular physiology and functions as a specific activator of many 
enzymatic reactions (Hambidge, 1989). This study shows a decrease (P < 0.05) in the mean plasma levels of Zn 
(Figure 2) in all the cancer patients except in breast cancer patients where there was no significant difference (P 
< 0.05) when compared with the control subjects. Zinc deficiency has been implicated in the development and 
progression in some cancers (Palmela et. al., 2010). The general trend towards a decrease in Zn concentration in 
the cancer patients as demonstrated in this study,  is in agreement with the results observed in cancerous liver 
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tissue by Kew and Mallet 1974.  However, among the cancer types, elevated level of Zn was recorded in breast 
cancer patients (6.40 + 0.01mmol/L) while the least value was found in leukemia patients (3.2 + 0.11µmol/L).  
The decrease in mean plasma zinc levels observed in the cancer patients in this study may be as a result of 
inadequate dietary zinc intake as well as the action of leucocytes in the redistribution of the body zinc from the 
serum to the liver during inflammation (Cunzhi et. al.,2003)  and its involvement in the antioxidant defense 
system  since the patients might be under higher oxidative stress . Zn has been proved to be an antioxidant or 
free-radical scavenger. It is an essential cofactor in a variety of enzymes and has antioxidant-like properties. 
Therefore, it can stabilize macromolecules against radical induced oxidation in vitro as well as limit excess 
radical production. Changes in Zn level in the blood of cancerous patients may be the cause of malignant tumor 
occurrence (Milde et.al.,  2004). 
 Iron, apart from its presence in all body cells, is the most abundant transition metal found in several 
tissues. It is involved in many processes including DNA, RNA and protein synthesis (Paralta et. al., 1994). 
Results obtained from this study showed that the mean plasma iron level (µmol/L) was not significantly different 
(P < 0.05) in breast, liver, colon, uterine and prostate (9.03 + 0.04 µmol/L, 13.22 + 0.02 µmol/L, 11.21 + 0.03, 
8.00 ± 0.02 cancer patients  cancer patients µmol/L and 10.10 + 0.04 µmol/L) cancer patients respectively; the 
mean value reduced significantly (P < 0.05) in ovarian and leukemia (5.21 + 0.05 µmol/L, and 3.02 + 0.01 
µmol/L) cancer patients respectively while a significant increase(p<0.05) was recorded in cervical (17.02 + 0.15 
µmol/L) cancer patients when compared with the control subjects (11.01 + 0.03 µmol/L) and among the cancer 
patients (Figure 2). Similar observation had been reported by Nora et.al., (2010). The significant decrease (P < 
0.05) observed in Fe levels in some cancer patients (ovarian, uterine and leukemia) in this study, may be 
attributed to progression in the growth of cancer (Robert et. al., 1994). The significant increase observed could 
be related to clinical anaemia and haematological abnormalities which were reported in some cancer cases 
resulting in the release of Fe from its store thus the increase of Fe in these cancer patients (Boehm et. al., 2007). 
However, these iron metabolism molecules may be an indicator of rates of cell proliferation or may influence the 
growth of cancer cells. (Robert et.al, 1994).  
 In this study, increase in the levels of plasma Cu (Figure 2) observed in prostate cancer patients could 
result from increased liver production of Cu as an inflammatory response in the tumor while decrease observed 
in other cancer types except in liver and cervical cancer patients may be due to the uptake of Cu from the blood 
by the cancer cells in promoting angiogenesis. However, this is in agreement with the report of Gupta et. al., 
1993. 
Normal cells are usually protected by antioxidant enzymes from the toxic effects of high concentrations 
of reactive oxygen species generated during cellular metabolism while cancer cells have been found to generate 
reactive oxygen species (ROS) (Milde, 2004). Selenium came into general knowledge as strongly toxic, but now 
it is considered as an essential element with several important roles in the human body. For example, it functions 
as an antioxidant with interrelationship with vitamin E, and component of the antioxidant enzyme glutathione 
peroxidase and as such as been involved in defense against oxidative stress (Carmia.,2004). Even though, it has 
been reported that selenium levels are low in most human cancers (Oberley 1997), this study has also supported 
this assertion because significant decrease (P < 0.05) in the levels of the plasma selenium levels (Figure 2) was 
recorded in all the cancer patients, when compared with the control subjects. However, the association between 
Se and cancer was strongest in prostate cancer as it has the lowest value in this type of cancer. Similar 
observation had been reported by Navarro-Alacron and Lopez (2000). Low concentration of Se in the plasma 
may be caused by the low Se content in food stuff, which mostly contributes to the intake of Se by human 
(Cunzhi et. al., 2003). The anticancer effect of Se has been supported by animal experiments, human 
epidemiological investigation and intervention trials (Spevackovavi and Knotkova 1998). Yet the mechanism of 
Se as an anticancer agent is not clear (Navarro-Alacron and Lopez 2000). 
The plasma levels of Mg and Mn were observed to be significantly different (P < 0.05) from the values 
obtained in the control subjects in all the cancer types (figures 3 and 4). The values however showed a 
significant decrease (p<0.05) when compared to the control. The decrease observed in the levels of these 
elements could be attributed to the fact that these elements are consumed in some metabolic pathways or 
replaced with carcinogenic metals in the occurrence and growth of cancer. This is in agreement with the work of 
Parsons and his colleagues (1974) who reported the regression of malignant tumors with hypo-magnesemia. Mg 
deficiency has been found to paradoxically increase the risk of, or protect against oncogenesis (Cortes and Moses, 
2007). It has been proposed that Mg is central in the cell cycle, and that its deficiency is an important conditioner 
in precancerous cell transformation (Cortes and Moses, 2007). Also low Mn in cancer patients may be due to its 
consumption by cancerous cells during the development of the cancer cells (Arinola and Charles Davies 2008). 
Figure 5 reveals increase in the plasma Ca levels of liver, colon, prostate and cervical cancer patients 
when compared to the control. The increase observed is in agreement with the work of Forte et al., 2005 and this 
could be attributed to progression in the growth of the cancer cells which might lead to the leakage of cancer 
from the bones tinto the blood stream or may be due to the inability of the kidneys to  remove excess calcium 
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from the blood. 
Lead and cadmium are non-essential toxic metals that have affinity for free sulphohydryl active site of 
enzymes and proteins. They are known to be human carcinogens based on findings of increased risk to lung 
cancer and pancreatic cancer among exposed workers (Jomova and Valko 2011). Reports have shown that 
selenium interacts with Pb and Cd in vivo. These interactions are part of natural metal detoxification process 
which could result in the metabolic inactiviation of Se, however, at high exposure levels, Pb and Cd may 
overtime produce a state akin to Se deficiency thereby aborting the cancer protecting effects of Se (Alatise, 
2010). This study however shows a significant increase (P < 0.05) in the plasma levels of Pb and Cd (Figure 6) 
in all the cancer types when compared to the control subjects and a significant increase was observed in liver 
cancer patients among other cancer patients. The elevated levels recorded in these metals could be attributed to 
their involvement in the generation of reactive oxygen species which could result in lipid peroxidation, DNA 
damage and altered gene expression (Kayode et. al., 2014), hence in the pathogenesis of cancer (Harouny, 2010). 
  
Conclusion 
The pattern of alteration in the levels of elements of the cancer patients observed in this study suggests that 
deficiency of elements may be a risk factor in the occurrence and progression of cancer and its complication. 
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